• Related Services
  • Related Locations
  • Awards
  • sector image

    sector image

    'Advisory Firm of the Year' - HealthInvestor Asia Awards 2018


Stephenson Harwood has a dedicated cross departmental healthcare team with members across its network of offices in Europe, Asia and the Middle East.  The team has significant experience of advising both public sector and private sector healthcare organisations and investors into the space including banks, venture capital, private equity and family offices.  
  • Profile
  • Experience
  • Key contacts

Its private healthcare team has advised numerous operators in the sector in Europe, Asia and the Middle East including private hospitals, care homes providers (including those providing care for the elderly, those with learning difficulties and those with mental illnesses) and retirement village operators. The team has also advised banks and investors in the space.

The public sector team advises on standalone public sector transactions, transactions between the public sector and the private sector and also assists the private healthcare team on transactions where the NHS experience is of great assistance.

Members of the public sector team have been involved in healthcare projects for over 25 years.  The team worked on the first "unconventional finance" projects whose genesis was the sale by the NHS of surplus land assets following the closure of large psychiatric hospitals.  These projects were a forerunner to PFI projects and private patient units ("PPUs").  The work has included acting for the relevant NHS bodies as well as for private sector providers and funders.

The healthcare and commercial issues for PPU and PFI projects have largely remained unchanged since the earliest projects such as the BMI Bishops Wood Hospital that is within Mount Vernon Hospital.  It was at Mount Vernon that our team members put together the contractual structure that has effectively been used ever since.  This structure has survived the test of time and is now standard market practice.

Our cross departmental team spans across a wide range of practice areas and has lawyers who can advise on all aspects of a healthcare transaction including corporate M&A, private equity, capital markets, real estate, commercial contracts, finance, competition, regulatory, IP, pensions and employment.

"Very professional, pragmatic, business-minded, knowledgeable team that advise as if they were part of the team. Very good quality-cost ratio.”
The Legal 500 UK 2022, Life sciences and healthcare

FPE Capital LLP

Advised FPE Capital on its investment in Togetherall, an online mental health platform.

Unigestion SA

Advised Unigestion SA on its investment in a single asset GP-led, organised by Archimedes Surgical in relation to Polyplus.

Apposite Capital

Advised Apposite Capital on its investment in medical device company, Emblation.

Apposite Capital

Advised Apposite Capital on its acquisition of Health and Case Management Limited.


Advised Civica on its acquisition of Malinko Health & Care Technologies Limited, the clinical e-scheduling specialists.


Advised Ascenti, a company portfolio company of bd-capital, on its acquisition of Six Physio.

Elysian Capital

Advising Elysian Capital, and the management team of the company, on the sale of Wellbeing Software to The Citadel Group, a company listed on The Australian Stock Exchange. Wellbeing is one of the UK's major healthcare software companies and is aligned to the UK National Health Service's long-term care agenda, with one or more of its solutions being used in 81% of NHS Trusts across England.

Bluecrest Health Screening

Advised the sellers on the sale of Bluecrest Health Screening Limited to Ambio Capital Limited.

Nexus Tradeco Limited

Acted for the property manager of Primary Health Properties plc on its £2.3 billion merger with Medicx fund, creating the UK's largest healthcare real estate investment trust.

Bowmark Capital

Advised Bowmark Capital on the £87 million disposal of CARE Fertility (CARE), a UK fertility clinic group for IVF treatment, to Silverfleet Capital.

NMC Health PLC

Advised NMC Health PLC on its acquisition of 100% of the issued share capital of HCN European Surgery Center Holdings limited, which owns 100% of Aspen Healthcare Limited ("Aspen"). Aspen operates a network of 9 facilities across the country including 4 hospitals, 3 of which are based in the Greater London market (Parkside Hospital, The Holly Private Hospital and Highgate Hospital).

Salutem Healthcare Limited

Advised Salutem Healthcare Limited on the acquisition of Clearwater Specialist Care Group Limited.

Salutem Healthcare Limited

Advised Salutem Healthcare Limited on the acquisition of various residential care home and education facilities and day care centres from SCOPE.


Advised HC-One on the £300 million acquisition of 122 care homes from Bupa, the international healthcare group.


Advised HC-One on its arrangements with AXA to operate UK based care facilities on behalf of AXA Investment Managers – Real Assets. This was following AXA IM – Real Assets' acquisition of Retirement Villages Group (RVG).

Salutem Healthcare Limited

Advised Salutem Healthcare Limited on the acquisition of Pathways Care Group Limited.

Salutem Healthcare Limited

Advised Salutem Healthcare Limited on the acquisition of Modus Care Limited.

Circle Health

Advised Circle Health in respect of its joint venture arrangements with VAMED GmbH.

Silk Healthcare

Advised the shareholders on the sale of luxury care homes operator Silk Healthcare to Methodist Homes.

Acadia Healthcare

Advised Acadia Healthcare on the acquisition of Priory Group, a leading provider of behavioural healthcare facilities in the United Kingdom.

Acadia Healthcare

Advised this US based provider of inpatient behavioural healthcare facilities on a US$662 million agreement to acquire Partnerships in Care.

KIMS Hospital

Advised on the restructuring of this private hospital in Kent including the sale of its shares and associated debt restructuring.

UK Specialist Hospitals (UKSH)

Advised on the sale of this specialist hospital group (that provides elective orthopaedic surgery to the NHS in the UK South West region) to Care UK.

Royal National Orthopaedic Hospital NHS Trust 

Advised the Royal National Orthopaedic Hospital NHS Trust on its projects to procure new hospital facility as well as a private patient unit on its site at Stanmore, North London.

University College Hospital NHS Foundation Trust and the Christie NHS Foundation Trust

Advised a medical equipment manufacturer bidding for contracts for the supply and maintenance of proton beam therapy equipment for the Department of Health's pilot projects.

Hospital project, Libya

Advised a bidder on the maternity and diagnostic hospital project in Libya.

Ministry of Justice

Advised the UK Ministry of Justice on projects for custodial and probation services that have involved significant elements of mental health and substance abuse services.  For example, we advised on a series of projects to build new PPP prisons. These included the outsourcing of custodial services, including the co-commissioning of healthcare and education (including substance misuse services).

Royal Bank of Scotland (‘RBS’)

Advised RBS on a number of transactions including: aspects of a loan facility of £355 million to London & Regional Properties Limited to buy a group of companies that owns 91 freehold nursing homes in the United Kingdom; the £30 million financing for the acquisition and development of a portfolio of care homes by Avery Healthcare; and aspects of a £165 million pay-in-kind facility, which formed part of an overall debt funding package of £1.4 billion used by investment house Three Delta LLP to buy Four Seasons Health Care from Allianz Capital Partners.  

Chandler Corporation 

Advised the Chandler Corporation on its investment into the Medical City in the Philippines and various investments in Indonesia, India, Bangladesh, Kenya, Pakistan and the United States.

Baring Private Equity Asia

Advised Baring Private Equity Asia on an investment in a healthcare company in Indonesia.

Healthcare Homes

Advised the sellers on the sale of Healthcare Homes, the leading elderly residential care provider in East Anglia, to Omega Healthcare, a US REIT, for a total consideration in excess of £115 million including a complex group re-organisation to split the properties from the operating business, to facilitate Omega Healthcare being able to acquire the target.

CARE Fertility

Advised on the acquisition of CARE Fertility, the UK’s leading independent provider of fertility treatments, genetic diagnosis and embryo screening techniques. It operates seven full-service clinics across the UK and Ireland, supported by a network of satellite centres.


Advised on the acquisition of Glenside. Glenside  provides specialist assessment, treatment and rehabilitation for adults with acute or long-term neurological conditions, including traumatic brain injury, through a complete range of rehabilitation services.


Advised on the acquisition and subsequent disposal of Kisimul, a long-established provider of quality education and care services to children and young adults with complex learning difficulties, challenging behaviour, autism and global developmental delay.

Advanced Childcare

Advised on the acquisition and disposal of Advanced Childcare, a specialist provider of residential care, education and foster care to young people with behavioural, emotional and social difficulties.


Advised on the acquisition and disposal of DATIX, a provider of patient safety and risk management software to the healthcare industry. Its products are used widely within both the public and private healthcare sectors.

Latest news & insights

09 Nov 2023

From News

Stephenson Harwood LLP advises on acquisition of the Hesley Group

Stephenson Harwood LLP has advised private investment fund Blandford Capital on its acquisition of UK adult educational and residential homes provider, Hesley Group, f..


08 Jun 2021

From News

Stephenson Harwood advises Apposite Capital on Emblation investment

Law firm Stephenson Harwood LLP has advised healthcare investor Apposite Capital on its investment in medical device company, Emblation.


19 May 2021

From News

Stephenson Harwood advises e-therapeutics plc on £22.5 million fundraise

​Law firm Stephenson Harwood LLP has advised e-therapeutics plc on a fundraise of £22.5 million.


17 May 2021

From News

Stephenson Harwood advises GE Healthcare on transformative Zionexa acquisition

​Law firm Stephenson Harwood LLP has advised GE Healthcare on the acquisition of Zionexa.


26 Mar 2021

From News

Stephenson Harwood advises Equitix on £40 million Rutherford Health investment ​

Law firm Stephenson Harwood LLP has advised Equitix Investment Management (Equitix) on its £40 million infrastructure investment with Rutherford Health. This marks Equ..


09 Jun 2020

From News

Stephenson Harwood advises Acacia Pharma Group on €10 million deal with Cosmo Pharmaceuticals

Law firm Stephenson Harwood LLP has advised Acacia Pharma Group plc in connection with a debt for equity swap, worth €10 million, with Cosmo Pharmaceuticals NV (Cosmo)..


17 May 2019

From News

Stephenson Harwood wins 'Law Firm of the Year' at the HealthInvestor Asia Awards 2019

Law firm Stephenson Harwood LLP has been named 'Law Firm of the Year' at the HealthInvestor Asia Awards 2019.


14 Feb 2019

From Insights

Medical devices regulation countdown

This regulatory topic has become increasingly pertinent, ahead of the countdown to the EU's new medical device and in-vitro diagnostic rules, set to take effect in May..


© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.